Medscheme prepares to deal with influx of positive Covid patients
Loading player...
Dr Lungi Nyathi – Managing Executive: Clinical Risk, Medscheme
Other recent episodes
[FULL SHOW] New Opec deal, market concentration, and citrus producers’ resilience
This evening, we wrap up the day’s market movements with Otto1890, we unpack the new Opec infrastructure deal with Econometrix, we examine the market concentration study and what it means for small businesses with the Competition Commission, we find out if there is still a business case for the City…
Market Watcher: All eyes on the US-China talks
David Shapiro of Otto1890 unpacks the US inflation which raises fears of interest rate hikes. However, equity markets are moving ahead strongly. Oil prices did end the day lower and US-Iran peace talks are not moving market sentiments. S&P and Nasdaq stocks are up particularly with the arrival of Trump…
SA gets R2.5bn boost to ease infrastructure constraints
Dr Azar Jammine – Director and chief economist, Econometrix
Despite shifts in concentration study, SMEs remain locked out
James Hodge – Chief economist, Competition Commission
Executive Lounge: Building the future of creativity, culture and tech
Ray Langa – Group CEO, Leagas Delaney South Africa